The Dementia Researcher, ISTAART Relay Podcast is back for a third, 5-part series. Where the interviewee becomes the interviewer. With five leading researchers discussing their research, their field, and the work of the Alzheimer’s Association ISTAART Professional Interest Area they represent.

Part Two – Dr Rik Ossenkoppele, interviews Dr Hamid Sohrabi representing the Resilience and Protective Factors PIA

Dr Rik Ossenkoppele is an Associate Professor of Translational Neuroscience at Amsterdam UMC and Lund University. His area of research is Alzheimer’s disease and other neurodegenerative disorders, brain imaging, biomarkers, cognition. Rik also happens to be a qualifiied PE Teacher, and he is representing the ISTAART Atypical Alzheimer's Disease PIA.

Dr Hamid Sohrabi is Director of the Centre for Healthy Ageing - Associate Professor of Psychology and Clinical Neurosciences at Murdoch University, Australia. His research is focussed on screening and clinical diagnostic measures as well as identifying dementia risk factors and resilience and resisting factors including cognitive reserve. Outside work he loves DIY (but never ask him to fit a gate in your garden). Hamid is representing the ISTAART Reserve, Resilience and Protective Factors PIA.

The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) convenes the global Alzheimer’s and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer’s and other dementias. Professional Interest Areas (PIA) are an assembly of ISTAART members with common subspecialties or interests.

There are currently 29 PIAs covering a wide range of interests and fields, from the PIA to Elevate Early Career Researchers to Biofluid Based Biomarkers and everything in between.

To sign-up to ISTAART (free for students worldwide, and for people of all grades in Low and Middle Income Countries) and a PIA visit:
[ Ссылка ]

To book your place at this years AAIC Confernence visit:
[ Ссылка ]

Visit our YouTube Channel to watch the video version of this podcast:
[ Ссылка ]

Find more information on our guests, and a full transcript of this podcast on our website at:
[ Ссылка ]
--

The views and opinions expressed by guests in this podcast represent those of the guests and do not necessarily reflect those of NIHR Dementia Researchers, PIA membership, ISTAART or the Alzheimer's Association.

-~-~~-~~~-~~-~-
Learn more about the new drugs coming to treat Alzheimer's Disea with this video podcast - "A Closer Look at Lecanemab, Donanemab and Amyloid"
[ Ссылка ]
-~-~~-~~~-~~-~-

свернуть